美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Flecainide Acetate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Flibanserin	Tablet	II (Paddle)	50	McIlvaine Buffer, pH 4.0 [61 mM Citric Acid solution + 77 mM dibasic sodium phosphate solution]. Measure the pH and adjust to 4.0, if necessary.	900	5, 10, 15, 20 and 30	2025/05/19
Fluconazole	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fluconazole (200 mg/5 mL)	Suspension			Develop a dissolution method			2023/09/15
Fluconazole (50 mg/5 mL)	Suspension			Develop a dissolution method			2023/09/15
Flucytosine	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fludarabine Phosphate	Tablet			Develop a dissolution method			2023/09/15
Fludrocortisone Acetate	Tablet			Refer to USP			2009/05/20
Fluoxetine	Capsules (Delayed Release)			Refer to USP			2007/07/25
Fluoxetine HCl	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fluoxetine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fluoxetine/Olanzapine	Capsule	II (Paddle)	50	0.1 N HCl	900	10, 20, 30 and 45	2006/08/17
Fluphenazine HCl	Tablet			Refer to USP			2017/11/02
Flutamide	Capsule			Develop a dissolution method			2024/01/03
Fluvastatin Sodium	Capsule			Develop a dissolution method			2024/01/03
Fluvastatin Sodium	Tablet (Extended Release)			Develop a dissolution method			2023/09/15
Fluvoxamine Maleate	Capsule (Extended Release)	II (Paddle)	50	Phosphate Buffer, pH 6.8	900	1, 2, 4, 6, 8 and 12 hours	2010/01/15
Fluvoxamine Maleate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Fosamprenavir Calcium	Oral Suspension	II (Paddle)	25	10 mM HCl	900	5, 10,15 and 20	2007/12/03
Fosamprenavir Calcium	Tablet	II (Paddle)	75	250 mM Sodium Acetate/Acetic acid buffer pH 3.5	900	10, 20, 30 and 45	2005/12/16